THe clinical observation of different doses of atorvastatin treatment of type 2 diabetes and dyslipidemia
Li Su
Abstract
Li Su
Abstract
Objective To observe the different doses of Atorvastatin in type 2 diabetic dyslipidemia in patients with clinical efficacy.Methods 97 cases of type 2 diabetes and dyslipidemia were randomly divided into A group of 31 cases of B-group of 34 patients in group C 32 patients,while in the conventional hypoglycemic night oral tablets atorvastatin group A 10 mg,B group 20 mg,C group 40 mg,After 8 weeks,the patient TC,TG,HDL-C,LDL-C,hs-CRP changes were analyzed.Results After 8 weeks,group B,group C,TC,TG,LDL-C levels were significantly lower than in group A (P0.05),B Group Group C HDL-C than in group A increased significantly (P0.05),hs-CRP level than the A group B group C was significantly decreased (P0.01).Group B and C no significant difference between groups,but group C compared with Group A Group B side-effects.Conclusion 20 mg atorvastatin tablets can not only improve dyslipidemia in type 2 diabetic patients with blood lipids,can also reduce plasma hs-CRP levels,has anti-inflammatory role of plaque stability.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the different doses of Atorvastatin in type 2 diabetic dyslipidemia in patients with clinical efficacy.Methods 97 cases of type 2 diabetes and dyslipidemia were randomly divided into A group of 31 cases of B-group of 34 patients in group C 32 patients,while in the conventional hypoglycemic night oral tablets atorvastatin group A 10 mg,B group 20 mg,C group 40 mg,After 8 weeks,the patient TC,TG,HDL-C,LDL-C,hs-CRP changes were analyzed.Results After 8 weeks,group B,group C,TC,TG,LDL-C levels were significantly lower than in group A (P0.05),B Group Group C HDL-C than in group A increased significantly (P0.05),hs-CRP level than the A group B group C was significantly decreased (P0.01).Group B and C no significant difference between groups,but group C compared with Group A Group B side-effects.Conclusion 20 mg atorvastatin tablets can not only improve dyslipidemia in type 2 diabetic patients with blood lipids,can also reduce plasma hs-CRP levels,has anti-inflammatory role of plaque stability.
Key concepts: Dyslipidemia, Medicine, Atorvastatin, Group B, Group A, Internal medicine, Type 2 diabetes, Gastroenterology